Clinical Trial Update: Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants [Phase 2, Phase 3]

View source ↗

Summary

A non-inferiority and safety study comparing EuTCV to Typbar-TCV in healthy participants aged 6 months to 45 years has completed Phase 2 and Phase 3 trials for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• EuTCV
• Typbar-TCV (Typhoid conjugate vaccine)

Snippet

Sponsor: EuBiologics Co.,Ltd | Conditions: Typhoid Fever | Phase 2, Phase 3 | Status: COMPLETED